WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies

Bookmark and Share
Published: 6 May 2014
Views: 1725
Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg

ecancer reporter, Peter Goodwin, chairs a roundtable discussion with Dr John Mendelsohn (The University of Texas MD Anderson Cancer Center, Houston, USA), Dr Razelle Kurzrock (Moores Cancer Center, San Diego, USA) and Dr Mace Rothenberg  (Pfizer Inc., New York, USA) about the goals of the WIN consortium and how these fields are highlighted at the annual WIN Symposium in Paris. Topics include personalised medicine, targeted molecules, and biomarkers in oncology.

The symposium will take place from the 23rd - 24th of June at the Marriott Rive Gauche Hotel in Paris, France.

ecancer members receive a discount on registration - login or join the ecancer club here.